NCT03264274View on ClinicalTrials.gov

Trial of Aflibercept Monotherapy With DCE-US in Chemorefractory Metastatic Colorectal Cancer

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 6, 2017

Primary Completion Date

February 6, 2017

Study Completion Date

February 6, 2017

Conditions
Colorectal Cancer
Interventions
DRUG

Aflibercept

Antiangiogenic

PROCEDURE

Dynamic Contrast Enhanced Ultrasound

DCE-US (a technique using differential liver blood flow assessments using microbubble) will be performed at baseline, Week 2 and 8 of treatment.

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Barts & The London NHS Trust

OTHER